AIGH Capital Management’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$700K Sell
739,910
-175,300
-19% -$173K 0.04% 43
2026
Q1
$740K Hold
915,210
0.1% 41
2025
Q4
$522K Sell
915,210
-130,840
-13% -$118K 0.13% 33
2025
Q3
$1.03M Buy
1,046,050
+71,525
+7% +$64.8K 0.29% 36
2025
Q2
$693K Buy
974,525
+242,370
+33% +$169K 0.31% 31
2025
Q1
$586K Sell
732,155
-78,942
-10% -$81.2K 0.24% 39
2024
Q4
$884K Buy
811,097
+309,663
+62% +$293K 0.28% 31
2024
Q3
$667K Hold
501,434
0.19% 35
2024
Q2
$450K Hold
501,434
0.14% 36
2024
Q1
$766K Buy
+501,434
New +$695K 0.23% 38

Other funds holding BFRI

AIGH Capital Management's BFRI Position: Q2 2026 in Review

AIGH Capital Management reduced its Biofrontera (BFRI) stake by 19% in Q2 2026, selling an estimated $173K and leaving 739,910 shares worth $700K. The position accounts for 0.04% of the portfolio, ranked #43.

AIGH Capital Management first reported a position in BFRI in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.03M in Q3 2025. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • AIGH Capital Management held 739,910 shares of Biofrontera worth $700K as of Q2 2026.
  • AIGH Capital Management sold 175,300 Biofrontera shares in Q2 2026, an estimated $173K.
  • Biofrontera made up 0.04% of AIGH Capital Management's portfolio in Q2 2026, its #43 holding.
  • AIGH Capital Management first reported a position in Biofrontera in Q1 2024 and has held it in 10 quarters since.
  • AIGH Capital Management's Biofrontera position peaked at $1.03M in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on AIGH Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.